Pfizer plans to acquire Agila Specialties: reports

India Infoline News Service | Mumbai |

Reports stated that the deal could be reached this quarter.

Pfizer Inc is planning to acquire India's Agila Specialties, the injectable-medicines unit of Indian drug supplier Strides Arcolab Ltd, for a possible price of $2 bn, according to reports.

Reports stated that the deal could be reached this quarter.

Agila makes cancer treatments and antibiotics.